Davion HealthCare
Non-invasive home tests for early medical anomaly detection.
About Davion HealthCare
Davion HealthCare Plc is a medical technology company that develops and commercializes non-invasive, at-home diagnostic tests for the early detection of various health anomalies, including those associated with cancers. The company was incorporated in Cyprus on November 29, 2022, and later redomiciled its corporate headquarters to Cork, Ireland, in September 2024 to align better with its core markets in the European Union and the United States. The leadership team includes Chief Executive Officer Jack Kaye and Non-Executive Chairman Sir Eric Peacock. Davion's business model has recently evolved from a capital-light, licensing-led model to a direct commercialization strategy. Previously, the company focused on designing and patenting medical products and then licensing the manufacturing, marketing, and distribution rights to partners. In June 2026, Davion terminated its existing global licensing arrangements for its flagship product to gain greater control over its product strategy and customer relationships. This strategic shift includes acquiring controlling interests in distribution companies like Solar Medical and Chemical Limited to establish its own commercial platform, initially in the United Kingdom. The company also continues to build its portfolio through strategic acquisitions, such as the proposed purchase of Humaskan Ltd, a medical technology company with proprietary intellectual property. The company's product pipeline features four non-invasive, remote health monitoring solutions that have met Class I regulatory standards in the US (FDA), Europe (CE), and the UK (UKCA). Its lead product, BreastCheck™, is an FDA-registered, at-home screening test that uses thermography to detect temperature variations in breast tissue, which can indicate potential anomalies. Other products in development include FootFlow, a test for diabetics to monitor blood flow in the extremities; Testic, for detecting testicular anomalies; and ThermaDerm, which monitors skin temperature across the body. These products are designed as early-warning systems, empowering individuals to monitor their health proactively from home and reducing the strain on healthcare systems. The company is in the process of a proposed direct listing on the Nasdaq Global Market under the ticker symbol "DAVI".
Source: Dealroom company dataAt a glance
- Status
- Listed
- Headquarters
- Cork, Ireland
- Listing
- IPO 2026
- Open positions
- None listed
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Oncology, medical testing, Non-Invasive medical devices and treatments
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company
- Capital deployed
- —
- Preferred round
- Unknown
- Links
- Website
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPO✓Exit | Oct 2026 | $0 | $306M | Undisclosed | ↗ |
| POST IPO DEBT✓Debt | Aug 2026 | $40M | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Davion HealthCare is 90 monthly website visits, down 66.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Qi Diagnostics LimitedNanosensor breathalyzers for health and disease detection. |
Hong Kong | Operational | 4 | — | — |
| Tokyo, Japan | Operational | ||||
The Blue BoxAI-powered urine test for breast cancer detection |
Barcelona, Spain | Operational | |||
Ruby NanomedNon-invasive cancer monitoring via circulating tumor cell isolation. |
Braga, Portugal | Operational | |||
Leuko LabsDeveloping the first device for non-invasive white cell monitoring |
Cambridge, United States | Operational | |||
TetraSync, Inc.Cellphone-based software for non-invasive colorectal cancer screening. |
Berkeley, United States | Operational | |||
LievaAI-powered diagnostic decision support for hematology oncology |
Çankaya, Türkiye | Operational | |||
CellswayMicrofluidic liquid biopsy platform for isolating tumor cells |
London, United Kingdom | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Davion HealthCare in the Cork ecosystem
The Davion HealthCare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Davion HealthCare on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Davion HealthCare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.

Davion agrees to buy Independence Care homecare network for up to $10M





